FibroBiologics and Charles River have announced the completion of FibroBiologics’ master cell bank for a product that will be evaluated for the treatment of diabetic foot ulcers and other chronic ...

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase ...

Medical honey proves effective against antibiotic-resistant bacteria, transforming wound care and offering hope in the fight ...

Wounds are more than just skin deep. They can affect every aspect of a person’s life, from mobility and independence to overall health and well-being. Whether you are dealing with ...

The global traditional wound management market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is categorized into gauze, bandages, ...

SolasCure has initiated a new Phase II clinical trial, CLEANVLU2, to further the development of its investigational product, ...

Mum Teresa Jones, 59, was diagnosed with Pyoderma Gangrenosum - a rare skin condition that causes large, painful ulcers to ...

A MUM begged doctors to amputate her leg after ‘bug bites’ turned out to be a flesh-rotting disease. Teresa Jones told how ...

In one advertisement, Fife flagged in 2023, a skin substitute representative whose company name has been redacted boasts of a ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Organogenesis Holdings Inc.’s ORGO share price has surged by 11.07%, which has investors questioning if this is right time to ...

Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...